Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much money was accrued to the public purse under the pharmaceutical price regulation scheme and (b) what proportion of that money was allocated to clinical commissioning groups between 2014 and 2019.
Under the 2014 Pharmaceutical Price Regulation Scheme (PPRS), scheme members made payments to the Department. The 2014 PPRS has now delivered over £2.7 billion of PPRS payments. The following table shows the annual aggregate PPRS payments from 2014 until the end of the PPRS in December 2018. The 2019 Voluntary Scheme for Branded Medicines Pricing and Access is the current voluntary scheme.
Period | Aggregate PPRS payments |
2014 | £311 million |
2015 | £847 million |
2016 | £628 million |
2017 | £387 million |
2018 | £615 million |
Further aggregate net sales and payment information can be found at the following link:
https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information
Each year, the Department estimates the England share of expected income from the PPRS which is then included within NHS England baseline financial allocations. Decisions on how to allocate funding across the health system is for NHS England to determine, in line with patient need.